ArticleProceedings of the National Academy of Sciences of the United States of America2024

Prevention efficacy of the broadly neutralizing antibody VRC01 depends on HIV-1 envelope sequence features.

Michal Juraska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.